Emily Park is a Principal at DCVC Bio. She works on later-stage value in early-stage therapeutics and computational biology companies, and previously worked in public markets as a biotech equities analyst.
What Emily can write
DCVC writes $10M to $30M+ checks, larger than 97% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: DCVC.Career
- Jefferies · Analyst, Healthcare Investment Banking
- Goldman Sachs · Global Investment Research team
- Point72 Asset Management · Biotech equities analyst
- DCVC Bio · Principal
- DCVC · Principal, DCVC BioNow
Focus
Also at DCVC
Partners like Emily
At firms with a similar stage, sector and check size.
Alert me when DCVC is active
One email when Emily's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Emily Park?
Emily Park is a Principal at DCVC Bio. She works on later-stage value in early-stage therapeutics and computational biology companies, and previously worked in public markets as a biotech equities analyst.
How much does Emily Park invest?
Emily Park invests through DCVC, which writes checks of $10M to $30M+ at seed, series a.
How do I pitch Emily Park?
Email [email protected], the firm's inbox for founders, and name Emily in the subject. A warm intro from a founder DCVC backed works better.
What did Emily Park do before DCVC?
Analyst, Healthcare Investment Banking at Jefferies; Global Investment Research team at Goldman Sachs; Biotech equities analyst at Point72 Asset Management; Principal at DCVC Bio.
Last updated 2026-10-15. Is this you? Ask for a correction.